Bellevue Emerging Markets Healthcare B CHF

Reference Data

ISIN LU1585228700
Valor Number
Bloomberg Global ID
Fund Name Bellevue Emerging Markets Healthcare B CHF
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s) Bank am Bellevue AG
Küsnacht
Phone: +41 44 267 67 67
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries.
Peculiarities

Fund Prices

Current Price * 104.88 CHF 30.10.2024
Previous Price * 107.66 CHF 29.10.2024
52 Week High * 122.19 CHF 08.11.2023
52 Week Low * 97.41 CHF 05.08.2024
NAV * 104.88 CHF 30.10.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 76,617,010
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance -4.97% 29.12.2023
30.10.2024
1 month -5.51% 30.09.2024
30.10.2024
3 months +1.71% 30.07.2024
30.10.2024
6 months +0.02% 30.04.2024
30.10.2024
1 year -11.10% 30.10.2023
30.10.2024
2 years -16.05% 31.10.2022
30.10.2024
3 years -41.72% 02.11.2021
30.10.2024
5 years -52.44% 15.06.2021
30.10.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Celltrion Inc 8.02%
Sun Pharmaceuticals Industries Ltd 6.12%
Innovent Biologics Inc 6.07%
Samsung BioLogics Co Ltd 5.34%
Legend Biotech Corp ADR 4.47%
BeiGene Ltd ADR 4.26%
Cipla Ltd 4.05%
Bangkok Dusit Medical Services PCL 3.41%
Apollo Hospitals Enterprise Ltd 3.39%
Chemical Works of Gedeon Richter PLC 2.85%
Last data update 31.08.2024

Cost / Risk

TER 2.29%
TER date 29.01.2021
Performance Fee *** 10.00%
PTR
Max. Management Fee *** 1.60%
Ongoing Charges *** 2.25%
SRRI ***
SRRI date *** 30.09.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)